Scott Brun
Direttore/Membro del Consiglio presso CABALETTA BIO, INC.
Patrimonio netto: - $ in data 31/05/2024
Posizioni attive di Scott Brun
Società | Posizione | Inizio | Fine |
---|---|---|---|
CABALETTA BIO, INC. | Direttore/Membro del Consiglio | 24/06/2021 | - |
Independent Dir/Board Member | 24/06/2021 | - | |
FORTE BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 10/11/2022 | - |
Independent Dir/Board Member | 10/11/2022 | - | |
JASPER THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 20/06/2023 | - |
Independent Dir/Board Member | 20/06/2023 | - | |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | Direttore/Membro del Consiglio | 12/02/2020 | - |
Gold Mast Consulting, LLC | Fondatore | 01/01/2019 | - |
Presidente | 01/01/2019 | - | |
Trishula Therapeutics, Inc.
Trishula Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trishula Therapeutics, Inc. is a company solely dedicated to developing TTX-030, a first-in-class anti-CD39 antibody aimed at improving outcomes for people with cancer. Trishula Therapeutics is based in South San Francisco, CA. The company's leadership, board of directors, scientific advisory board, investors, and partners are all committed to this goal. Anil Singhal has been the CEO of the company since 2021. | Direttore/Membro del Consiglio | - | - |
Abingworth Management, Inc.
Abingworth Management, Inc. Investment ManagersFinance Abingworth Management, Inc. invests in life sciences and biomedical companies. The firm's investment in enables technologies, devices and instrumentation as well as companies developing products in therapeutic areas. The company was founded in 1973 and is headquartered in Menlo Park, CA. | Investitore di Private Equity | - | - |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Consulente / Consigliere | - | - |
Storia della carriera di Scott Brun
Precedenti posizioni note di Scott Brun
Società | Posizione | Inizio | Fine |
---|---|---|---|
ABBVIE INC. | Corporate Officer/Principal | - | 01/03/2019 |
░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formazione di Scott Brun
University of Illinois At Urbana–Champaign | Undergraduate Degree |
The Johns Hopkins University School of Medicine | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 13 |
Posizioni
Director/Board Member | 5 |
Independent Dir/Board Member | 3 |
Corporate Officer/Principal | 2 |
Settori
Health Technology | 7 |
Finance | 4 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 5 |
---|---|
ABBOTT LABORATORIES | Health Technology |
ABBVIE INC. | Health Technology |
CABALETTA BIO, INC. | Health Technology |
FORTE BIOSCIENCES, INC. | Health Technology |
JASPER THERAPEUTICS, INC. | Finance |
Aziende private | 5 |
---|---|
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | Health Technology |
Gold Mast Consulting, LLC | |
Trishula Therapeutics, Inc.
Trishula Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trishula Therapeutics, Inc. is a company solely dedicated to developing TTX-030, a first-in-class anti-CD39 antibody aimed at improving outcomes for people with cancer. Trishula Therapeutics is based in South San Francisco, CA. The company's leadership, board of directors, scientific advisory board, investors, and partners are all committed to this goal. Anil Singhal has been the CEO of the company since 2021. | Health Technology |
Abingworth Management, Inc.
Abingworth Management, Inc. Investment ManagersFinance Abingworth Management, Inc. invests in life sciences and biomedical companies. The firm's investment in enables technologies, devices and instrumentation as well as companies developing products in therapeutic areas. The company was founded in 1973 and is headquartered in Menlo Park, CA. | Finance |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Finance |
- Borsa valori
- Insiders
- Scott Brun
- Esperienza